The pioneering collaboration completed the licensing of the first Apollo-supported project, a novel gene therapy programme developed at University College London (UCL)
The pioneering collaboration completed the licensing of the first Apollo-supported project, a novel gene therapy programme developed at University College London (UCL)
$635 Million in Real Estate and Multi-Disciplinary Laboratory Infrastructure Will Combine With Multi-Billion Dollar Investments in Research to Transform the Battle Against Disease